U.S. Congress

281 - 300 of 993 Results

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Wrapping Up Summer鈥檚 Health News

    President Joe Biden has signed the Inflation Reduction Act and Congress is gone until after Labor Day. But the administration and lawmakers left lots of health policy achievements behind, including new rules to facilitate the sale of over-the-counter hearing aids and a potential reorganization of the Centers for Disease Control and Prevention. Anna Edney of Bloomberg News, Alice Miranda Ollstein of Politico, and Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Also, for extra credit, the panelists suggest their favorite health policy stories of the week they think you should read, too.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: A Big Week for Biden

    Congress is leaving for its annual summer break having accomplished far more than many expected, including, barring unforeseen snags, a bill to address the cost of prescription drugs for Medicare beneficiaries and extend the enhanced subsidies for insurance premiums under the Affordable Care Act. Meanwhile, the abortion issue continues to roil the nation as Indiana becomes the first state to ban the procedure in almost all cases since the Supreme Court overruled the constitutional right to abortion in June. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Kansas Makes a Statement

    In the first official test vote since the Supreme Court overturned Roe v. Wade, voters in Kansas鈥 primary said in no uncertain terms they want to keep a right to abortion in their state constitution. Meanwhile, the Senate is still working to reach a vote before summer recess on its health care-climate-tax measure, but progress is slow. Tami Luhby of CNN, Sandhya Raman of CQ Roll Call, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Bram Sable-Smith, who wrote the latest KHN-NPR 鈥淏ill of the Month鈥 installment about a very expensive ambulance trip.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Manchin Makes a Deal

    In a rare surprise for official Washington, Senate Majority Leader Chuck Schumer and Sen. Joe Manchin (D-W.Va.) announced a deal to expand the planned health bill in the Senate to include provisions raising taxes and addressing climate change. The measure would include a third year of expanded subsidies for the Affordable Care Act, but not health care coverage for people left out of Medicaid in states that failed to expand the program. Meanwhile, the ACA goes back to court, and the Biden administration restores anti-discrimination protections for LGBTQ+ people that were rolled back by the Trump administration. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. C茅line Gounder of KHN about the latest on the monkeypox outbreak.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Drug Price Bill Is a Go in the Senate

    Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: The FDA Goes After Nicotine

    The FDA is using its power to regulate tobacco products 鈥 ordering the vaping device Juul off the market and announcing its intention to lower the amount of nicotine in cigarettes and other products. Meanwhile, the Supreme Court rules on Medicare and kidney dialysis, and Congress makes progress on legislation surrounding guns and mental health. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN鈥檚 Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN鈥檚 Noam N. Levey about the new KHN-NPR project on the growing impact of medical debt.

  • Podcast

    KHN鈥檚 鈥榃hat the Health?鈥: Closing In on Covid Vaccines for 鈥楾he Littles鈥

    The wait is nearly over for parents of kids under 5 as a key advisory committee to the FDA recommends authorizing a covid-19 vaccine for the youngest children. Meanwhile, Congress is struggling to fill in the details of its gun control compromise, and, as the Supreme Court prepares to throw the question of abortion legality back to the states, the number of abortions has been rising. Shefali Luthra of The 19th, Sarah Karlin-Smith of the Pink Sheet, and Sandhya Raman of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.

  • A close up photo shows a surgical face mask discarded on the ground.
    Perspective

    Will the US Overcome Its Covid Complacency Even as the Threat Returns?

    One million Americans have died from covid-19 鈥 far more per capita than in any other developed country. A new variant is doubling case rates in some states, and more than 300 people are dying a day. But our nation鈥檚 pandemic response has become mild-mannered and performative, backed by neither money, urgency, nor enforcement.